| dc.contributor.author |
Mahesh, R. |
|
| dc.date.accessioned |
2023-11-20T09:08:12Z |
|
| dc.date.available |
2023-11-20T09:08:12Z |
|
| dc.date.issued |
2013-11 |
|
| dc.identifier.uri |
https://academic.oup.com/jpp/article/66/1/122/6128065 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13185 |
|
| dc.description.abstract |
The inconsistent therapeutic outcome necessitates identifying novel compounds for the treatment of depression. Therefore, the present study is aimed at evaluating the antidepressant-like effects of a novel 5-HT3 receptor antagonist 3-methoxy-N-p-tolylquinoxalin-2-carboxamide (QCM-4) on chronic unpredictable mild stress (CUMS) induced behavioral and biochemical alterations in mice. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Oxford |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
5-HT3 antagonist |
en_US |
| dc.subject |
Chronic unpredictable mild stress (CUMS) |
en_US |
| dc.subject |
Immobility time |
en_US |
| dc.subject |
Lipid peroxidation |
en_US |
| dc.subject |
Sucrose |
en_US |
| dc.title |
QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice |
en_US |
| dc.type |
Article |
en_US |